Bad News For Democrats: Drug Costs Drop Without Their Help

  • by: |
  • 01/08/2007
Two more pieces of good news about how markets and competition that will no doubt disappoint Democrats and those who would rather see drug companies die than see more people live from their increased investments...

Articles in the Health Affairs that came in the mail today show that rate of increase in drug spending declined faster than it has in over a decade from 2004-5. Meanwhile healthcare spending in the US essentially remained the same. (All this is happening by that way even as the number of people using meds and the number of prescriptions increases..) Other articles showed that increased spending on medicines for hypertension contributed to a decline in deaths and spending on more costly medical services. Moreover, the studies found that if more people had actually taken the medicines prescribed the cost offset and benefits would have been even greater.

Now what does that tell us class?

First, that from 2004-5 even as seniors began to increase the number of prescriptions they took with the help of prescription drug card, the rate of increase declined. That's because more people took generics and price competition kept prices down. Also, new formulations were more cost effective.

Second, increased drug utilization is associated with a decline in health care spending. As the studies on medicines and cardiovascular disease shows -- studies conducted by Harvard's David Cutler and associates -- drugs that control the progress of chronic illness also control the rate of health care spending. The more they are used, the more they do so

Third, the earlier and more frequently we treat disease with medicine the more likely we prevent disease and control its cost as well as improve life. Therefore drugs are undervalued.

And that class, is the problem. The Left truly hates the drug companies and therefore seeks to devalue its products at every turn. Either they claim they are me-too pieces of crap, poisonous pills that they payoff the FDA to market, or way to expensive cancer drugs that marginally increase survival. They can't think of one drug that truly makes a difference.

The latest research shows, yet again, they are wrong. And they are venal.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog